Stoneridge (SRI) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
15 May, 2026Executive summary
Q1 2026 sales reached $160.8 million, up 9.2% sequentially, driven by record MirrorEye sales, higher off-highway and Brazil OEM sales, and favorable foreign currency translation.
Adjusted gross margin expanded by 400 basis points to 21.7% compared to Q4 2025, reflecting manufacturing improvements and lower quality-related costs.
Net loss was $27.0 million, including a $9.2 million loss on disposal of Control Devices; adjusted net loss was $20.9 million.
Announced two major business awards totaling over $135 million in estimated lifetime revenue, including a new OEM-integrated MirrorEye program and next-gen electronic controls.
Sale of Control Devices segment completed January 2026, resulting in a strategic shift to technology-led growth and operational excellence.
Financial highlights
Q1 2026 sales were $160.8 million, up 9.2% sequentially and 7.9% year-over-year, with adjusted gross profit of $35.0 million (21.7% margin).
Adjusted EBITDA was $2.0 million (1.3% margin), exceeding break-even expectations.
Adjusted operating loss improved to $(3.0) million (–1.8% margin) from Q4 2025.
Net debt improved by $42.0 million to $85.9 million, aided by proceeds from the Control Devices sale.
Cash and cash equivalents at quarter-end were $70.5 million; borrowings on Credit Facility were $156.5 million.
Outlook and guidance
Full-year 2026 revenue guidance raised to $645–$670 million, reflecting $20 million incremental contract manufacturing revenue.
Adjusted operating margin guidance updated to approximately break-even to 0.5%, up 50 basis points from prior expectations.
Adjusted EBITDA guidance reaffirmed at $20–$25 million (3.1%–3.7% margin); adjusted gross margin guidance at 21.5%–22.0%.
Second quarter revenue expected to be slightly above Q1, with EBITDA improvement anticipated in the second half of the year.
Commitment to reduce structural costs by at least $5 million in 2026.
Latest events from Stoneridge
- Annual meeting covers director elections, auditor ratification, compensation, and ESG oversight.SRI
Proxy filing9 Apr 2026 - Annual meeting covers director elections, auditor ratification, and incentive plan amendment.SRI
Proxy filing9 Apr 2026 - 2025 outperformed end markets with 69%–70% MirrorEye growth and strong 2026 targets.SRI
Q4 202512 Mar 2026 - Q2 2024 saw margin gains, EPS growth, and updated guidance as key tech launches accelerated.SRI
Q2 20242 Feb 2026 - Control Devices sold for $59M to focus on advanced electronics and reduce debt.SRI
Status update2 Feb 2026 - MirrorEye and Smart 2 drive growth through innovation, safety, and regulatory compliance.SRI
CL King’s 22nd Annual Best Ideas Conference 202420 Jan 2026 - Q3 sales and earnings declined, but cash flow and MirrorEye adoption showed improvement.SRI
Q3 202417 Jan 2026 - Growth driven by MirrorEye, Smart 2, and operational improvements despite market softness.SRI
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026 - MirrorEye/Mirai and Smart 2 growth offset market declines, driving margin and cash flow gains.SRI
Q4 202426 Dec 2025